GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Techno Medica Co Ltd (TSE:6678) » Definitions » ROCE %

Techno Medica Co (TSE:6678) ROCE % : 11.03% (As of Dec. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Techno Medica Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Techno Medica Co's annualized ROCE % for the quarter that ended in Dec. 2023 was 11.03%.


Techno Medica Co ROCE % Historical Data

The historical data trend for Techno Medica Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Techno Medica Co ROCE % Chart

Techno Medica Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.34 8.87 10.90 11.99 10.15

Techno Medica Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.51 20.21 2.03 11.30 11.03

Techno Medica Co ROCE % Calculation

Techno Medica Co's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2023 )  (A: Mar. 2022 )(A: Mar. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2023 )  (A: Mar. 2022 )(A: Mar. 2023 )
=1649.453/( ( (18508.245 - 2630.205) + (19443.171 - 2810.442) )/ 2 )
=1649.453/( (15878.04+16632.729)/ 2 )
=1649.453/16255.3845
=10.15 %

Techno Medica Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=1617.84/( ( (17815.667 - 1997.35) + (15582.431 - 2071.367) )/ 2 )
=1617.84/( ( 15818.317 + 13511.064 )/ 2 )
=1617.84/14664.6905
=11.03 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Techno Medica Co  (TSE:6678) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Techno Medica Co ROCE % Related Terms

Thank you for viewing the detailed overview of Techno Medica Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Techno Medica Co (TSE:6678) Business Description

Traded in Other Exchanges
N/A
Address
5-5-1 Nakamachidai, Tsuzuki-ku, Yokohama, JPN, 224-0041
Techno Medica Co Ltd is engaged in the research, development, manufacturing, and sales of medical and in vitro diagnostic products. The company's products classified under Test Tube preparation systems. Additionally, company also import and export medical equipment and Analytical instrument for clinical examination.

Techno Medica Co (TSE:6678) Headlines

No Headlines